title: Management of ventricular tachycardia in heart failure.
abstract: Ventricular tachyarrhythmias are common in patients with congestive heart failure. The clinical presentation ranges from an asymptomatic incidental electrocardiographic finding to palpitations, syncope, and sudden cardiac death. Although implantable cardioverter defibrillators successfully prevent sudden cardiac death associated with ventricular fibrillation and ventricular tachycardia, recurrent implantable cardioverter defibrillators shocks remain a clinical management challenge. In this review, we discuss management strategies of ventricular tachycardia in congestive heart failure, including drug therapy, radiofrequency catheter ablation (RFCA), and recent RFCA advances.
authors.affiliation: The Methodist Hospital, Houston, Texas, USA.
authors.forename: Alex
authors.initials: A
authors.lastname: Baher
authors.forename: Miguel
authors.initials: M
authors.lastname: Valderrabano
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017115:Catheter Ablation / Q000009:adverse effects; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000295:instrumentation; D000431:Ethanol / Q000008:administration & dosage; D006333:Heart Failure / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D012008:Recurrence; D017180:Tachycardia, Ventricular / Q000175:diagnosis / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D000431:Ethanol
keywords: antiarrhythmic drugs; congestive heart failure; radiofrequency catheter ablation; sudden cardiac death; ventricular tachycardia